Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuron (IMRN) Operating Leases (2019 - 2022)

Immuron's quarterly Operating Leases came in at $150263.8 in Q2 2022, up 851.97% year-on-year from $15784.6 in Q2 2021, and up 851.97% quarter-over-quarter from $15784.6 in Q2 2021.

Immuron has reported Operating Leases for 4 years, with the latest figure at $150263.8 in Q2 2022.

  • For the quarter ending Q2 2022, Operating Leases rose 851.97% year-over-year to $150263.8; the trailing twelve-month figure through Jun 2022 stood at $150263.8 (up 851.97% YoY), and the FY2022 full-year result was $150263.8, up 851.97% from the prior year.
  • Operating Leases for Q2 2022 stood at $150263.8, up from $15784.6 in the prior quarter.
  • The five-year high for Operating Leases was $150263.8 in Q2 2022, with the low at $15784.6 in Q2 2021.
  • Average Operating Leases over 4 years is $61116.7, with a median of $39209.2 recorded in 2019.
  • Year-over-year, Operating Leases sank 60.59% in 2021 and soared 851.97% in 2022.
  • Tracing IMRN's Operating Leases over 4 years: stood at $38369.0 in 2019, then gained by 4.38% to $40049.5 in 2020, then slumped by 60.59% to $15784.6 in 2021, then soared by 851.97% to $150263.8 in 2022.
  • The last three Operating Leases figures came in at $150263.8 (Q2 2022), $15784.6 (Q2 2021), and $40049.5 (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Immuron 1.27 Bn 1.27 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 150,263.78
Jun 30, 2021 15,784.59
Jun 30, 2020 40,049.48
Dec 31, 2019 38,369.00